Drug Discovery Online
Drug Discovery Online is a B2B digital content and marketplace platform, operated by VertMarkets, Inc., that serves pharmaceutical and biotechnology professionals in early-stage drug discovery via editorial content, virtual events, and CRO/CDMO sourcing centers across the drug development pipeline.
- Company typePrivate
- Founded1996
- HeadquartersErie, United States
- Headcount51–100
- GTM typeB2B
- OfferingDigital Commerce or Content
What Drug Discovery Online does
Drug Discovery Online is a B2B digital marketplace and content platform operated by VertMarkets, Inc. (founded 1996, headquartered in Erie, PA) that serves pharmaceutical and biotechnology professionals working in early-stage drug discovery and development. The platform delivers curated editorial content across bioinformatics, regulatory affairs, target research, innovation, preclinical development, and entrepreneurship, and is organized around six specialized sourcing centers (Research Partners, Cellular Models, Target Discovery, Assay & Screening, Imaging & Translational Models, and Analytical Characterization) that connect research organizations with named CRO/CDMO and instrument providers including Curia, Emulate, Lonza, X-Chem, BD Biosciences, Cytiva, INTEGRA Biosciences, and QIAGEN.
The underlying technology is a web-based content management and digital publishing platform with video hosting for on-demand webinars and expert discussions, supporting the Drug Discovery Online Live interactive forum series. Distribution is exclusively digital via the drugdiscoveryonline.com website, email newsletter, and virtual event streaming, with registration required for full content access.
The business model combines a freemium top-of-funnel newsletter subscription for lead capture with paid premium subscriptions gating full content, archived webinars, and sourcing resources. Marketing and audience reach are amplified through the parent company's Life Science Connect network of 14+ life sciences publications, enabling cross-promotion across adjacent verticals such as bioprocessing, clinical research, and cell and gene therapy. The company employs 51-100 staff, maintains a claimed global geographic footprint, and reports no disclosed revenue, funding rounds, M&A activity, or external institutional investment.
Drug Discovery Online firmographics
Firmographics- Name
- Drug Discovery Online
- Legal name
- Drug Discovery Online (operated by VertMarkets, Inc.)
- Website
- https://drugdiscoveryonline.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Drug Discovery Online is a B2B digital content and marketplace platform, operated by VertMarkets, Inc., that serves pharmaceutical and biotechnology professionals in early-stage drug discovery via editorial content, virtual events, and CRO/CDMO sourcing centers across the drug development pipeline.
- Ownership category
- akta.pro rank
Drug Discovery Online industry classification
Industry- Product category
- Pharmaceutical & Biotechnology Industry Media
- NAICS
- Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers (516210)
- akta.pro primary industry
- Topic/Interest-Based Content Discovery Apps (MPACAKAB)
Keywords
Where Drug Discovery Online is headquartered
LocationHeadquarters
- HQ city
- Erie
- HQ country
- United States
- HQ region
- North America
Markets served
Drug Discovery Online business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Subscription/Content Access: Revenue generated through subscription-based access to premium editorial content, research partner sourcing resources, and archived webinars. Free newsletter available for lead generation with paid subscriptions for full content access.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free Newsletter Subscription |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Drug Discovery Online product offering
Product offeringCore offering
Drug Discovery Online operates a B2B digital marketplace that delivers curated editorial articles, white papers, case studies, application notes, and news across the drug development pipeline (bioinformatics, regulatory, target research, innovation, preclinical, entrepreneurship). It also runs interactive video forums (Drug Discovery Online Live) and a network of partner sourcing centers that connect pharmaceutical and biotechnology researchers with CDMOs, CROs, and technology providers such as Curia, Lonza, Emulate Inc, and X-Chem. The platform uses a freemium model with a free newsletter for lead generation and premium subscriptions for full content access.
Product overview
Drug Discovery Online is a digital marketplace and content platform for the drug development industry, offering a unified portal that combines editorial content, newsletters, video events, and partner sourcing centers. The core offering is the Digital Marketplace (drugdiscoveryonline.com) which provides articles, white papers, videos, and news across topics including Bioinformatics, Regulatory, Target Research, Innovation, Preclinical, and Entrepreneurship. Supporting products include Drug Discovery Online Live (interactive video forums), and a network of Sourcing Centers (Research Partners, Cellular Models, Target Discovery, Assay & Screening, Imaging & Translational Models, and Analytical Characterization) that connect researchers with industry providers such as Curia, Emulate Inc, Lonza, X-Chem, BD Biosciences, Cytiva, INTEGRA Biosciences, and QIAGEN.
Differentiator
Problem solved
Functional benefit
Brands
- Drug Discovery Online Live: Interactive forum featuring video sessions and discussions on innovations and strategies shaping drug development
- Life Science Connect
Products and services
- Drug Discovery Online Digital Marketplace
Companies that use Drug Discovery Online
Customer profileSegments3 records
Ideal customer profiles3 records
Drug Discovery Online technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Drug Discovery Online partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- CuriacoreCuria is featured as a research partner within the Drug Discovery Online Research Partners Sourcing Center. Curia is a global Contract Development and Manufacturing Organization (CDMO) with over 30 years of experience offering services across Small Molecules, Generic APIs, and Biologics. The partnership provides Drug Discovery Online users access to Curia's drug discovery, development, and manufacturing capabilities.
- Emulate InccoreEmulate Inc is featured as a research partner offering Organ-on-a-Chip technology through Drug Discovery Online's platform. The Human Emulation System provides research organizations access to human-relevant biological models for drug discovery and development applications.
- LonzacoreLonza is featured as a research partner offering pharmaceutical and biotech services including PBPK predictive modeling and bioconjugate development. The partnership provides Drug Discovery Online users access to Lonza's global manufacturing and scientific expertise.
- X-ChemcoreX-Chem is featured as a research partner providing DNA-encoded library (DEL) technology and small molecule discovery services. The partnership offers Drug Discovery Online users access to DEL screening capabilities and computational drug discovery platforms.
- BD BiosciencesminorBD Biosciences is featured in the Cellular Models Sourcing Center offering flow cytometry instruments and reagents for drug development applications including T-cell research and CAR cell development.
- CytivaminorCytiva is featured in the Cellular Models Sourcing Center providing upstream platforms for gene therapy applications and cell therapy workflows. Products include ÄKTA, Amersham, Biacore, and HyClone brands.
- INTEGRA BiosciencesminorINTEGRA Biosciences is featured in the Cellular Models Sourcing Center offering liquid handling and media preparation solutions for research, diagnostics, and quality control laboratories.
- Precision Medicine World Conference (PMWC)minorPMWC is promoted as an event partner through the Drug Discovery Online platform. The conference is featured as a recommended industry event for pharmaceutical and biotech professionals.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
Drug Discovery Online competitors and assessment
Company assessmentDirect peers
- Drug Discovery & Development: Drug Discovery & Development is a dedicated B2B publication and digital platform covering the drug discovery pipeline. It is a direct competitor to Drug Discovery Online in editorial coverage of target identification, screening, and preclinical development.
- Outsourced Pharma: Outsourced Pharma is a B2B digital media platform covering pharmaceutical outsourcing, CDMOs, CROs, and contract services. It directly overlaps with Drug Discovery Online's Research Partner Sourcing Centers and shares audience with CDMO/CRO sponsors.
- BioCentury: BioCentury is a premium subscription-based B2B intelligence service covering biotech, drug development, and pharma strategy. It competes with Drug Discovery Online for senior-level pharma/biotech decision-maker attention and subscription revenue.
- Endpoints News: Endpoints News is a subscription-based B2B publication focused on drug development and biopharma industry intelligence. It competes directly with Drug Discovery Online for paid subscribers and breaking news coverage in the drug discovery space.
- Fierce Biotech (Questex): FierceBiotech is an established B2B digital publication covering drug discovery, biotech, and pharma industry news with newsletters and virtual events. It competes directly with Drug Discovery Online for the same pharmaceutical/biotech professional audience and advertiser dollars.
- Genetic Engineering & Biotechnology News (GEN): GEN is a long-standing B2B publication covering drug discovery, biotechnology, and life sciences research. It directly competes with Drug Discovery Online in editorial content, audience engagement, and sponsor relationships across biotech R&D professionals.
- BioSpace: BioSpace is a leading digital media and job platform serving the biopharmaceutical and drug discovery industries. It directly competes with Drug Discovery Online for audience attention, editorial reach, and sponsorship revenue across pharma/biotech professionals.
Broad incumbents
- PharmaTimes: PharmaTimes is an established B2B publication covering the pharmaceutical industry including drug discovery, clinical development, and commercial operations. It overlaps with Drug Discovery Online in pharma news coverage and competes for advertising/sponsorship revenue.
- BioWorld (Clarivate): BioWorld is a premium intelligence service within Clarivate covering biopharma R&D, clinical development, and deal-making. As part of Clarivate's broader life sciences portfolio, it competes with Drug Discovery Online in subscription-based drug discovery intelligence.
Regional players
- Labiotech.eu: Labiotech is a European-focused B2B digital media platform covering biotechnology and drug development. It competes with Drug Discovery Online for European biotech audience and sponsorships but is concentrated in EU rather than global coverage.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Drug Discovery Online social profiles
Digital presenceDrug Discovery Online financial estimates
Financial estimateRevenue estimate
Valuation estimate
Drug Discovery Online leadership team
Management profileNumber of profiles
Profiles1 record
Drug Discovery Online funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Drug Discovery Online M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Drug Discovery Online
What does Drug Discovery Online do?
Drug Discovery Online operates a B2B digital marketplace that delivers curated editorial articles, white papers, case studies, application notes, and news across the drug development pipeline (bioinformatics, regulatory, target research, innovation, preclinical, entrepreneurship). It also runs interactive video forums (Drug Discovery Online Live) and a network of partner sourcing centers that connect pharmaceutical and biotechnology researchers with CDMOs, CROs, and technology providers such as Curia, Lonza, Emulate Inc, and X-Chem. The platform uses a freemium model with a free newsletter for lead generation and premium subscriptions for full content access.
Is Drug Discovery Online a public or private company?
Drug Discovery Online is a private company. It is classified as corporate owned and is currently operating.
When was Drug Discovery Online founded?
Drug Discovery Online was founded in 1996. It employs 51 to 100 people.
Where is Drug Discovery Online based?
Drug Discovery Online is headquartered in Erie, United States, in the North America region.
How does Drug Discovery Online make money?
One revenue line is on record: subscription/Content Access.
Who are Drug Discovery Online's main competitors?
Direct peers on record are Drug Discovery & Development, Outsourced Pharma, BioCentury, Endpoints News, Fierce Biotech (Questex), Genetic Engineering & Biotechnology News (GEN) and BioSpace. Broad incumbents are PharmaTimes and BioWorld (Clarivate). Labiotech.eu is listed as a regional player.
Does Drug Discovery Online have an API?
No public API is recorded for Drug Discovery Online.
What industry is Drug Discovery Online in?
Drug Discovery Online's product category is Pharmaceutical & Biotechnology Industry Media. Its primary akta.pro industry code is MPACAKAB, Topic/Interest-Based Content Discovery Apps. Its NAICS code is 516210.